Loading…
Based on limited metadata, the FDA issued a warning letter to Epro E-Commerce Limited (operating as DealExtreme and DX.com) on June 29, 2020, regarding medical devices sold through their e-commerce platform. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined, though the warning likely concerns unapproved, misbranded, or adulterated medical devices being distributed through their online channels. The letter falls under FDA medical device regulatory authority and suggests the company was either directly manufacturing, importing, or distributing medical devices without proper compliance with FDA requirements.